Phase 1 Study of Autologous Sirpα-Low Macrophages (SIRPant-M) Administered By Intratumoral Injection Alone or in Combination with External-Beam Radiotherapy in Patients with Relapsed or Refractory Non-Hodgkin Lymphoma (NCT05967416)

SIRPant-M (RB-1355) - Bobcatbio

https://ash.confex.com/ash/2023/webprogram/Paper175040.html

Paolo Strati, MD1; Tatyana Feldman, MD2; Christiane Querfeld, MD, PhD3; Salvia Jain, MD4; Nathanael McCurley, PhD5; Rita Bàrcia, PhD5; Koby Kidder, PhD5; Jelle Kylstra, MD, MBA5

Nov 3, 2023